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S U M M A R Y
The clinical, microbiological, and histopathological ﬁndings of six patients with mucosal leishmaniasis
are reported. Five of these patients were Spanish with no history of travel abroad, while the other was
from Bolivia but had lived in Spain for more than 5 years. Two patients had no underlying disease, while
the other four had several other medical conditions. Lesions were located in the nose in three patients
and in the larynx in the other three. Symptoms included difﬁculty in swallowing, nasal obstruction,
dysphonia, and polypoid lesions mimicking cancer. The diagnosis was based on the identiﬁcation of
parasites, or on PCR assay or culture. Five patients were treated with liposomal amphotericin B and the
other with antimonial compounds.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Mucosal leishmaniasis (ML) is characterized by mucosal
destruction, with mucous membrane involvement of the nose,
oral cavity, pharynx, or larynx. The symptomatology of the disease
depends on the localization of lesions and may include nasal
obstruction, swallowing difﬁculties, mucosal bleeding, and/or
hoarseness.
Most ML cases are observed in Latin America and are due to
Leishmania braziliensis,1 and ML rarely results from infection by
other Leishmania species. However, there have been a few reports
that Leishmania infantum may cause localized mucosal disease in
the absence of concomitant visceral or cutaneous leishmaniasis.2
These lesions often mimic cancers, with no samples being sent for
microbiological diagnosis.
Six cases of ML caused by L. infantum are reported, highlighting
the need for a correct differential diagnosis of this entity.* Corresponding author. Tel.: +34 958020072.
E-mail address: fernando.cobo.sspa@juntadeandalucia.es (F. Cobo).
http://dx.doi.org/10.1016/j.ijid.2016.08.003
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Methods
Six patients were diagnosed with ML by the microbiology
laboratory of Virgen de las Nieves University Hospital (Granada,
Spain) between 2010 and 2013. All patients gave their informed
consent for inclusion in this study. At the time of diagnosis, these
patients were living in Granada (Andalusia), an area endemic for
leishmaniasis in Spain. The initial diagnosis was made in the
hospital by visualization of Leishmania amastigotes in Giemsa-
stained smears in four of six patients (the results of an in-house
nucleic acid ampliﬁcation test (NAAT) were negative for these
patients) and by in-house NAAT for the other two. Culture results
were positive for all patients.
All isolates were then sent to the National Centre of
Microbiology (Majadahonda, Madrid, Spain) for species identiﬁca-
tion, which was carried out with a speciﬁc nested PCR for
L. infantum.3 This PCR consists of a ﬁrst ampliﬁcation with
Kinetoplastida-speciﬁc primers R221 and R332, followed by a
second ampliﬁcation with Leishmania-speciﬁc primers R223 and
R333. Positive and negative controls were included.3 For Leish-
mania culture, clinical samples were inoculated into minimumciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Main characteristics of the six patients with mucosal leishmaniasis caused by Leishmania infantum
Patient
1 2 3 4 5 6
Age (years)/sex 49/M 43/M 66/F 42/M 67/F 36/M
Country of origin Spain Spain Spain Bolivia Spain Spain
Travel history No No No No Cyprus, Tunis No
Concomitant disease or
condition
Hypercholesterolemia,
drinker
HIV + HCV + ex
IVDU
Rheumatoid
arthritis
No Diabetes mellitus,
arterial hypertension,
asthma, steroid
treatment
No
Location of infection Nose Nose Nose Soft palate,
larynx
Larynx Larynx
Clinical manifestation Nasal obstruction,
crusted lesions in
nose
Painful lesions
of the nasal
vestibule
Nasal cellulitis Odynophagia,
dysphonia,
weight loss
Dysphonia, dyspnoea,
cough
Dysphonia,
tumour lesion
in the larynx
Biopsy of the lesions
(stain)
Positive, Giemsa Positive, Giemsa Negative Negative Positive, Giemsa Positive, Giemsa
Histopathology Non-speciﬁc
inﬂammatory
inﬁltrate
Non-speciﬁc
inﬂammatory
inﬁltrate
Granulomatous
inﬂammatory
reaction
Granulomatous
inﬂammatory
reaction
Granulomatous
inﬂammatory
reaction
Granulomatous
inﬂammatory
reaction
Culture Positive Positive Positive Positive Positive Positive
PCR Positivea Positivea Positiveb Positiveb Positivea Positivea
Treatment Liposomal
amphotericin B
Liposomal
amphotericin B
Liposomal
amphotericin B,
meglumine
antimoniate
Liposomal
amphotericin B
Liposomal
amphotericin B
Meglumine
antimoniate
Serology ND ND ND 1/80 (IFAT) ND Negative (IFAT)
M, male; F, female; HIV, human immunodeﬁciency virus; HCV, hepatitis C virus; IVDU, intravenous drug abuser; PCR, polymerase chain reaction; ND, not done; IFAT,
immunoﬂuorescence antibody test.
a Positive at the National Centre of Microbiology (Madrid, Spain) by nested PCR.
b Positive at the authors’ laboratory by in-house nucleic acid ampliﬁcation tests and further conﬁrmed at the National Centre of Microbiology.
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supplemented with 20% foetal calf serum.4
Table 1 shows the characteristics of the six patients with ML
due to L. infantum.
3. Case reports
3.1. Case 1
A 48-year-old Spanish man required medical attention for nasal
obstruction, inﬂammation, and crusted lesions in the nasal
mucosa. He was a former smoker and current moderate drinker.
He had two dogs, one of which had leishmaniasis. Physical
examination revealed an erythematous lesion in the nasal wing
and cheek but no other ﬁndings of interest. A complete blood
count, urinalysis, and chemical proﬁle were normal.
Histological examinations of a biopsy of the lesion revealed a
non-speciﬁc inﬂammatory inﬁltrate with Leishmania species
amastigotes in the tissue. Culture of the biopsy specimen was
also positive for Leishmania. The lesions disappeared after
treatment with liposomal amphotericin B (300 mg/day) for
9 days.
3.2. Case 2
A 43-year-old Spanish man with no history of foreign travel was
evaluated for a painful lesion of the nasal vestibule extending to
the upper lip. The patient was diagnosed with HIV infection and
had positive hepatitis C virus (HCV) antibodies. He was undergoing
antiretroviral treatment and had a viral load of 199 239 copies/ml
(5.30 log). His CD4+ T-cell count was 181 (9%). A complete blood
count, urinalysis, and chemical proﬁle were all normal.
Histological examinations of a biopsy of the lesion revealed a
non-speciﬁc inﬂammatory inﬁltrate with the presence of Leish-
mania species amastigotes in the tissue. Culture of the biopsy
specimen was also positive for Leishmania. The patient receivedliposomal amphotericin B (300 mg/day) for 9 days, with a positive
outcome.
3.3. Case 3
A 66-year-old Spanish woman with no history of foreign travel
was evaluated for nasal cellulitis involving the left wing of the nose.
She was receiving treatment with steroids and inﬂiximab for
rheumatoid arthritis. A complete blood count and chemical proﬁle
were normal. Histological examinations of three biopsies revealed a
granulomatous inﬂammatory reaction with no amastigote visuali-
zation. Culture from a new biopsy grew promastigotes of
Leishmania. A nested PCR was also performed, with a positive result.
Treatment started with liposomal amphotericin B (300 mg/
day), but resulted in arterial hypertension and lumbar pain; the
treatment was therefore changed to meglumine antimoniate
(20 mg/kg per day). The lesion disappeared after 3 weeks of this
treatment.
3.4. Case 4
A 42-year-old Bolivian man, a resident of Spain since 2004, was
referred in 2010 for suspected cancer after the detection of a
papillomatous lesion located in the soft palate and larynx.
Symptoms included odynophagia and dysphonia with weight loss.
A complete blood count and chemical proﬁle were normal.
Anti-Leishmania antibodies were detected at a titre of 1:80 by
indirect immunoﬂuorescence assay test.
A granulomatous chronic inﬂammatory inﬁltrate was observed
in biopsies of the oral lesions. Histological examinations with
Giemsa staining revealed no intracellular amastigotes of Leish-
mania. A new biopsy was taken and a nested PCR was performed,
with a positive result. Culture from this tissue grew promastigotes
of Leishmania.
The patient was treated with liposomal amphotericin B
(200 mg/week) for 5 weeks, with no improvement. A new cycle
Figure 1. Indirect laryngoscopy showing a tumour-like lesion in the larynx of the
patient (case 6) after a 7-month period with dysphonia.
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achieved total resolution of the lesions.
3.5. Case 5
A 67-year-old Spanish woman was referred with a 6-month
history of dysphonia and a 1-week history of cough and dyspnoea.
The patient had diabetes mellitus and was undergoing treatment
with steroids for asthma. She had travelled to Tunis and Cyprus
several years earlier.
Indirect laryngoscopy showed multiple lesions with a granulo-
matous appearance in the larynx. A biopsy of the lesions showed a
granulomatous inﬂammatory inﬁltrate with Giemsa-stained
Leishmania amastigotes. Culture of the biopsy specimen was also
positive for promastigotes of Leishmania.
The lesions disappeared after 5 weeks of treatment with
liposomal amphotericin B (300 mg/day).
3.6. Case 6
A 36-year-old Spanish man with diabetes mellitus and asthma
was evaluated after a 7-month period with dysphonia. He reported
no history of foreign travel. Indirect laryngoscopy showed a lesion
with a tumour-like appearance (Figure 1), and a biopsy was then
performed. Direct examination of the Giemsa-stained sample
showed abundant Leishmania amastigotes, and culture was
positive for Leishmania. A granulomatous inﬂammatory inﬁltrate
was also observed.
An indirect immunoﬂuorescence assay test for Leishmania was
negative. Bone marrow aspiration for parasite examination was
also negative. A complete blood count, chemical proﬁle, urinalysis,
and cell immunity study were all normal.
The lesions disappeared after treatment with meglumine
antimoniate (850 mg/day) for 28 days.
4. Discussion
Mucosal leishmaniasis is a rare disease even in endemic areas. It
is usually encountered in Latin America,2 but has occasionally been
recorded in other locations.5
L. infantum infections are endemic in the Mediterranean area
and may cause localized mucosal disease, even in the absence of
concomitant visceral or cutaneous leishmaniasis.
In the present study, dysphonia was observed in the three
individuals with laryngeal lesions, while nasal alterations were
recorded in the other three. The disease was only considered
severe in one patient who suffered from acute dysphonia due to
laryngeal involvement.The diagnosis of ML is usually established by the detection of
Leishmania amastigotes in Giemsa-stained lesion smears or by the
observation of promastigotes in cultured tissue samples.6 Howev-
er, there are sometimes too few parasites in the lesions to be
detected by microscopy or culture. In these cases, PCR-based
assays offer highly sensitive and speciﬁc detection of the
Leishmania parasite. In this study, PCR was only performed for
the two patients with a negative microscopic examination.
Leishmania amastigotes were demonstrated by Giemsa stain in
the remaining cases.
Serology is rarely used as a diagnostic technique in ML, because
the sensitivity and speciﬁcity can be variable and the number of
circulating antibodies against Leishmania tends to be low. An
indirect immunoﬂuorescence assay for anti-Leishmania antibodies
was done for two of the patients, but was positive for only one of
them, at a titre of 1:80.
Histopathological study of the lesions can often contribute to
the diagnosis of a Leishmania infection, even when no Leishmania
amastigotes are detected by microscopy.7 In all of the present
patients, the macroscopic appearance of the lesions led to an initial
clinical suspicion of cancer. These patients need to be examined
carefully to rule out cancer and other diseases. However, patients
with mucosal lesions that have a mixed inﬂammatory inﬁltrate
should be considered potential cases of leishmaniasis in those
living in or visiting endemic areas. If a Leishmania infection is
suspected, a sample should be sent to the microbiology laboratory
for differential diagnosis. In four of the study patients, histopa-
thology showed a granulomatous appearance but no cancer cells
were observed, and no Leishmania amastigotes were found in two
of these. This emphasizes the usefulness of the histological study of
lesions for the diagnosis of this infection.
Pentavalent antimonial drugs may be used as treatment, but
because of several serious side-effects and their variable efﬁcacy
against ML, alternative treatment regimens can be used, such as
liposomal amphotericin B or pentamidine. Five of the study
patients were treated with liposomal amphotericin B, although
this was changed to pentavalent antimonials in one case due to
adverse effects. Treatment was successful in all patients.
In conclusion, leishmaniasis caused by L. infantum should be
considered in the differential diagnosis of patients travelling to or
residing in an endemic area and who have mucosal lesions and
some of the rhinolaryngeal symptoms reported above. In these
cases, a biopsy of the affected tissues should be taken for
microbiological and histopathological diagnosis in order to allow
the prompt initiation of anti-Leishmania treatment.
Conﬂict of interest: The authors declare no conﬂict of interest.
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